JPS63156707A - Cosmetic containing hyaluronic acid - Google Patents

Cosmetic containing hyaluronic acid

Info

Publication number
JPS63156707A
JPS63156707A JP61302922A JP30292286A JPS63156707A JP S63156707 A JPS63156707 A JP S63156707A JP 61302922 A JP61302922 A JP 61302922A JP 30292286 A JP30292286 A JP 30292286A JP S63156707 A JPS63156707 A JP S63156707A
Authority
JP
Japan
Prior art keywords
hyaluronic acid
molecular weight
cosmetic
lotion
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP61302922A
Other languages
Japanese (ja)
Inventor
Yoshio Hiraki
平木 吉夫
Shoji Yamamoto
正二 山本
Satoshi Yoshikawa
聡 吉川
Hidetaka Omine
大峰 秀高
Koji Miyazaki
幸司 宮崎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yakult Honsha Co Ltd
Original Assignee
Yakult Honsha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Co Ltd filed Critical Yakult Honsha Co Ltd
Priority to JP61302922A priority Critical patent/JPS63156707A/en
Priority to US07/038,907 priority patent/US5023175A/en
Priority to CA000535098A priority patent/CA1314508C/en
Priority to AU71960/87A priority patent/AU598809B2/en
Priority to KR1019870003999A priority patent/KR960005736B1/en
Priority to EP87106247A priority patent/EP0244757B1/en
Priority to DE3750733T priority patent/DE3750733T2/en
Publication of JPS63156707A publication Critical patent/JPS63156707A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/02Preparations for cleaning the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46Streptococcus ; Enterococcus; Lactococcus

Abstract

PURPOSE:To obtain a cosmetic having high moisture-retaining property and excellent applicability such as spreadability on the skin, moistness, smoothness (softness) to the skin, etc., and useful as cream, milky lotion, face lotion, pack, etc., by using hyaluronic acids having a specific molecular weight as a component. CONSTITUTION:Hyaluronic acid or its salt having a molecular weight of >=2,000,000 is used as a component of the objective cosmetic. Hyaluronic acid can be separated from a cultured product produced by culturing a microbial strain belonging to Streptococcus zooepidemicus [e.g. Streptococcus zooepidemicus YIT203 (FERM P-8746)] under aerobic condition preferably at 25-38 deg.C. The amount of the hyaluronic acids in the cosmetic is preferably 0.05-2.0wt%. the cosmetic may be properly incorporated with various lubricant, surfactant, preservative, viscosity modifier, drug-active component, perfumery, alcohol, water, etc., and used in the form of face lotion, hair rinse, hair treatment, shampoo, etc.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は保湿効果が高く、使用感に優れた化粧料に関す
る。
DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a cosmetic that has a high moisturizing effect and is comfortable to use.

〔従来の技術〕[Conventional technology]

化粧料の具備すべき性質のうち、保湿性は化粧料を皮膚
に適用した場合の外界からの刺激や肌あれを防ぎ、また
使用感を向上せしめるため特に重要である。そして、従
来よシ化粧料に保湿性を持たせるため、種々の検討がな
されている。例えば、化粧料に、?ジオール類、皮膚成
分、生体高分子等の保湿(保水)剤が配合されている。
Among the properties that cosmetics should have, moisturizing properties are particularly important because they prevent irritation from the outside world and skin roughness when cosmetics are applied to the skin, and improve the feeling of use. Conventionally, various studies have been made to impart moisturizing properties to cosmetics. For example, in cosmetics? Contains moisturizing (water retaining) agents such as diols, skin ingredients, and biopolymers.

皮膚成分、中でもヒアルロン酸□は、人の皮膚中の水分
保有に関与していると言われ、最近化粧料に配合されて
優れた保湿効果を発揮している〔フレグランスシャーナ
ル墓79.64〜71頁(1986):l。
Skin components, especially hyaluronic acid □, are said to be involved in retaining moisture in human skin, and have recently been incorporated into cosmetics to exhibit excellent moisturizing effects [Fragrance Sharnal Tomb 79.64~ p. 71 (1986): l.

〔発明が解決しようとする問題点〕[Problem that the invention seeks to solve]

しかしながら、従来化粧料に配合されているヒアルロン
酸は分子量30万〜150万程度のものであシ、その保
湿効果は未だ満足すべきものではなかった。
However, the hyaluronic acid conventionally blended into cosmetics has a molecular weight of about 300,000 to 1,500,000, and its moisturizing effect has not yet been satisfactory.

〔問題点を解決するための手段〕[Means for solving problems]

そこで本発明者らは、更に優れた保湿効果を有する物質
を検索していたところ、本出願人が先に特許出願(特願
昭61−99446号)した分子量200万以上のヒア
ルロン酸が従来のヒアルロン酸に比べ優れた保湿効果を
有し、これを配合すれば保湿効果及び使用感に優れた化
粧料が得られることを見い出し、本発明を完成した。
Therefore, the present inventors searched for a substance with an even better moisturizing effect, and found that hyaluronic acid with a molecular weight of over 2 million, for which the present applicant had previously applied for a patent (Japanese Patent Application No. 61-99446), The present invention was completed based on the discovery that it has a moisturizing effect superior to that of hyaluronic acid, and that by blending it, a cosmetic with excellent moisturizing effect and feel on use can be obtained.

すなわち、本発明は分子量200万以上のヒアルロン酸
またはその塩を含有することを特徴とする化粧料を提供
するものである。
That is, the present invention provides a cosmetic material containing hyaluronic acid or a salt thereof having a molecular weight of 2 million or more.

本発明において使用されるヒアルロン酸は、分子量が2
00万以上であれば製法については特に限定されないが
、例えば、特願昭61−99446号に記載した方法に
よって、分子量200万以上のヒアルロン酸を生産する
微生物を栄養培地にて培養し、該培養物から採取するこ
とによって製造される。
The hyaluronic acid used in the present invention has a molecular weight of 2
The production method is not particularly limited as long as the molecular weight is 2,000,000 or more, but for example, a microorganism that produces hyaluronic acid with a molecular weight of 2,000,000 or more is cultured in a nutrient medium by the method described in Japanese Patent Application No. 61-99446. Manufactured by extracting from something.

上記方法において、分子量200万以上のヒアルロン酸
を生産する微生物としては、当該ヒアルロン酸生産能を
有し、ヒアルロニダーゼ非生産性でかつ非溶血性を示す
ストレゾトコツカス属に属する細菌、例えば次の如くし
て得られるストレプトコツカス・ズーエピデミカスの変
異株1株が挙げられる。すなわち、まず鼻粘膜よシヒア
ルロニダーゼ(ヒアルロン酸分解酵素)の強い生成能を
有しかつヒアルロン酸を生産するランスフィールド血清
群C型に属するストレプトコツカス・ズーエピデミカス
(本菌の同定は、バージエイズ・マニュアル・オブ・デ
ターミネイティブ・バクテリオロゾイー第8版、197
4によった)を得る。この菌株はマツクレナン(Mac
Lennan 。
In the above method, microorganisms that produce hyaluronic acid with a molecular weight of 2 million or more include bacteria belonging to the genus Strezotococcus that have the ability to produce hyaluronic acid, are non-productive of hyaluronidase, and are non-hemolytic, such as the following: One mutant strain of Streptococcus zooepidemicus obtained in this way is mentioned. First, the nasal mucosa is Streptococcus zooepidemicus, which has a strong ability to produce hyaluronidase (hyaluronic acid degrading enzyme) and belongs to Lancefield serogroup C, which produces hyaluronic acid.・Of Determinative Bacteriorozoes, 8th edition, 197
4) is obtained. This strain is known as pine crenan (Mac).
Lennan.

J、Gen、Microbiol、、 14 、134
−142 、1956 )が指摘したように好気条件に
おいてヒアルロン酸を良く生産し、炭素源としてグルコ
ースを用いた場合、4チのグルコース添加によって2t
/!のヒアルロン酸を生産した(ヒアルロン酸の、対糖
収率は5%)。そしてこの時得られたヒアルロン酸の分
子量は30−60万であった。この菌株を常法(細菌・
ファージ遺伝実検法、蛋白質核酸酵素別冊、共立出版1
972)によって紫外線や化学剤(N−メチル−N’−
二トローN−ニトロソグアニジン(NTG)、エチルメ
タンスルフォン酸等)で処理して、この処理菌体を血液
寒天培地に混釈してまき、溶血性を示さない集落を採取
し、次にこの菌株を再び変異処理した後、ヒアルロン酸
を含有した栄養寒天培地上に塗布し、ヒアルロン酸を分
解しない集落を採取することによってストレプトコツカ
ス・ズーエピデミカスの変異株1株を得る(後記参考例
1参照)。
J,Gen,Microbiol,, 14, 134
142, 1956), when hyaluronic acid is produced well under aerobic conditions and glucose is used as a carbon source, 2 tons can be produced by adding 4 hours of glucose.
/! of hyaluronic acid was produced (the yield of hyaluronic acid based on sugar was 5%). The molecular weight of the hyaluronic acid obtained at this time was 300,000 to 600,000. This strain is extracted using the conventional method (bacteria,
Phage Genetic Testing Method, Protein Nucleic Acid Enzyme Separate Volume, Kyoritsu Publishing 1
972) by ultraviolet rays and chemical agents (N-methyl-N'-
Nitro N-nitrosoguanidine (NTG), ethylmethanesulfonic acid, etc.), the treated bacterial cells were mixed and spread on a blood agar medium, a colony that did not show hemolytic properties was collected, and then this strain After mutating it again, it is spread on a nutrient agar medium containing hyaluronic acid, and a colony that does not degrade hyaluronic acid is collected to obtain a mutant strain of Streptococcus zooepidemicus (see Reference Example 1 below). .

斯くシて得られるストレプトコツカス・ズーエピデミカ
スの変異株1株(以下本菌といつ)ハ、トッド・ヒュイ
ット・ブロス(ToddHewitt broth )
寒天培地上で極めて強い粘性を有する透明な集落を形成
し、非溶血性(β−溶血性:陰性)、ヒアルロニダーゼ
非生産性、ランスフィールド血清群C型に属する連鎖状
球菌であシ、本菌の菌学的性質は下記の通シである。
One mutant strain of Streptococcus zooepidemicus thus obtained (hereinafter referred to as the present strain) is Todd Hewitt broth.
This bacterium forms transparent colonies with extremely strong viscosity on an agar medium, is non-hemolytic (β-hemolytic: negative), non-hyaluronidase-producing, belongs to Lancefield serogroup C, and is a streptococcus that belongs to Lancefield serogroup C. The mycological properties of this species are as follows.

(a)ダラム染色性:陽性 (b)io℃増殖性:陰性 (e) 45℃増殖性:陰性 (d) 0.1%メチレンブルー抵抗性:陰性(e) 
6.5%食塩抵抗性:陰性 (f) 40%胆汁抵抗性:陰性 (X)バシトラシン抵抗性:陽性 (h) pH9,6抵抗性:陰性 (i)60℃、30分抵抗性:陰性 (j)ゼラチン分解性:陰性 (6)澱粉分解性:陽性 (1)馬尿酸ソーダ分解性:陰性 (ホ)エスクリン分解性二弱陽性 (n)アルギニン分解性:陽性 (0)糖醗酵性ニゲルコース、ガラクトース、シューク
ロース、ラクトース、マルトース、ソルビトールおよび
サリシンは陽性、グリセリン、マンニトール、トレハロ
ースおよびアラビノースは陰性。
(a) Durham staining: positive (b) IO°C growth: negative (e) 45°C growth: negative (d) 0.1% methylene blue resistance: negative (e)
6.5% salt resistance: Negative (f) 40% bile resistance: Negative (X) Bacitracin resistance: Positive (h) pH 9,6 resistance: Negative (i) 60°C, 30 minutes resistance: Negative ( j) Gelatin decomposition property: Negative (6) Starch decomposition property: Positive (1) Sodium hippuric acid decomposition property: Negative (e) Aesculin decomposition property: Weak positive (n) Arginine decomposition property: Positive (0) Sugar fermentation nigercose , galactose, sucrose, lactose, maltose, sorbitol, and salicin, and negative for glycerin, mannitol, trehalose, and arabinose.

本発明者らは本菌の菌学的性質から、本菌をストレゾト
コツカスーズーエビデミカスYIT 2030と命名し
、工業技術院微生物工業技術研究所に微工研菌寄第87
46号として寄託した。
Based on the mycological properties of this bacterium, the present inventors named this bacterium Strezotococca zuevidemicus YIT 2030, and submitted it to the National Institute of Microbiological Technology, Agency of Industrial Science and Technology as part of the 87th Microbiological Research Institute.
It was deposited as No. 46.

次に本菌を培養して、該培養物から分子量200万以上
のヒアルロン酸を採取する方法について説明する。
Next, a method for culturing this bacterium and collecting hyaluronic acid having a molecular weight of 2 million or more from the culture will be described.

本菌を培養してヒアルロン酸を得る培地は、炭素源、有
機・無機窒素源およびその他必要に応じて無機塩や有機
微量栄養素を含有するものであることが好ましい。炭素
源としては、グルコース、ガラクトース、シュークロー
ス、ラクトース、フラクトース、マルトース、ソルビト
ール、澱粉加水分解物等の糖分を含むものが好ましく、
他には有機酸や脂肪族アルコール等でもよい。窒素源と
しては有機・無機を問わず一般的な材料でよいが、各種
肉エキス、アミノ酸混合物、ペプトン、酵母エキス等が
好ましい。更に、ナトリウム、カリウム、カルシウム、
毎グネシウム、鉄等の塩化物、硫酸塩、燐酸塩、硝酸塩
、炭酸塩そしてビタミンなどが必要に応じて添加されう
る。
The medium for culturing this bacterium to obtain hyaluronic acid preferably contains a carbon source, an organic/inorganic nitrogen source, and other inorganic salts and organic micronutrients as necessary. As the carbon source, those containing sugar such as glucose, galactose, sucrose, lactose, fructose, maltose, sorbitol, and starch hydrolyzate are preferable.
Other examples include organic acids and aliphatic alcohols. As the nitrogen source, common materials, organic or inorganic, may be used, but various meat extracts, amino acid mixtures, peptone, yeast extract, etc. are preferable. Furthermore, sodium, potassium, calcium,
Chlorides, sulfates, phosphates, nitrates, carbonates, vitamins, etc. of magnesium, iron, etc. may be added as necessary.

培養は好気的条件が必須であシ、培養液の粘度の上昇に
応じ攪拌速度を上げるのが良いが過度の攪拌は好ましく
ない。培養温度は菌の増殖が行われる25−38℃が好
ましい。
Aerobic conditions are essential for culturing, and it is preferable to increase the stirring speed as the viscosity of the culture solution increases, but excessive stirring is not preferred. The culture temperature is preferably 25-38°C at which bacterial growth occurs.

更に培養時、本菌が乳酸を生成しその乳酸によって菌の
増殖ならびにヒアルロン酸の生産が抑制されることから
、乳酸の中和の為にアルカリ水溶液を添加して、培養液
のpHを6−8の範囲内に調整するのが好ましい。この
時使用するアルカリ水溶液としては、例えば水酸化ナト
リウム、水酸化カリウムの水溶液やアンモニア水が挙げ
られる。
Furthermore, during culturing, this bacterium produces lactic acid, which inhibits the growth of the bacterium and the production of hyaluronic acid. Therefore, an alkaline aqueous solution is added to neutralize the lactic acid, and the pH of the culture solution is adjusted to 6-6. It is preferable to adjust it within the range of 8. Examples of the alkaline aqueous solution used at this time include aqueous solutions of sodium hydroxide and potassium hydroxide, and aqueous ammonia.

本菌は高分子量のヒアルロン酸(分子量200万以上)
を極めて高い収率、生産率で生産する菌株であるが、炭
素源としてグルコースを用いると特に良い結果かえられ
る。すなわち、グルコースを添加すると目的とするヒア
ルロン酸の生産率が極めて向上し、その添加量は0.5
−6 %が好ましい。
This bacterium has high molecular weight hyaluronic acid (molecular weight over 2 million)
This strain produces extremely high yields and production rates, and particularly good results are obtained when glucose is used as the carbon source. In other words, adding glucose significantly improves the production rate of the desired hyaluronic acid, and the amount added is 0.5
-6% is preferred.

本菌は高分子物質として、ヒアルロン酸以外の物質を培
養液中に蓄積しないので、培養後、培養液中に蓄積され
たヒアルロン酸の分離、精製は容易で、既に公知の多糖
類の分離精製法を用いればよい。
Since this bacterium is a polymeric substance and does not accumulate substances other than hyaluronic acid in the culture solution, it is easy to separate and purify the hyaluronic acid accumulated in the culture solution after culturing, and it is already known to separate and purify polysaccharides. Just use the law.

ヒアルロン酸の分離、精製法の一例を示す。An example of a method for separating and purifying hyaluronic acid is shown.

培養液を適当な粘度となるように(100センチ?アズ
以丁が好ましい)水で希釈し、トリクロル酢酸にてpH
を4以下にする。次いで遠心分離あるいは膜濾過(?ブ
ーサイズ0.2μm以下)によって菌体を分離除去する
Dilute the culture solution with water to an appropriate viscosity (preferably 100cm thick), and adjust the pH with trichloroacetic acid.
to 4 or less. Next, the bacterial cells are separated and removed by centrifugation or membrane filtration (diameter: 0.2 μm or less).

次ぎに溶液中に溶解している低分子物質を、限外濾過、
透析、有機溶媒沈澱法又はイオン交換樹脂等による吸着
法などによって除去した後、有機溶媒沈澱法、凍結乾燥
又は噴霧乾燥などの手段を用いて分子量200万以上の
ヒアルロン酸を得ることができる。
Next, the low molecular weight substances dissolved in the solution are removed by ultrafiltration.
After removal by dialysis, organic solvent precipitation, adsorption using an ion exchange resin, etc., hyaluronic acid with a molecular weight of 2 million or more can be obtained using methods such as organic solvent precipitation, freeze drying, or spray drying.

このようにして上記培養液から抽出精製して得たヒアル
ロン酸について、ヒアルロン酸標品(分子量約63万、
Sigma社製)と対比しながら種々の検討を行った結
果、本品はヒアルロン酸であることを確認した。以下に
その性質を示す。
Regarding the hyaluronic acid obtained by extraction and purification from the above culture solution in this way, a hyaluronic acid standard (molecular weight approximately 630,000,
As a result of various studies while comparing the product with Sigma (manufactured by Sigma), it was confirmed that this product is hyaluronic acid. Its properties are shown below.

(1)酢酸セルロース膜を用いる電気泳動において標品
と同じ移動度を示す。
(1) Shows the same mobility as the standard sample in electrophoresis using a cellulose acetate membrane.

(2)放線菌ヒアルロニダーゼ(大野製薬製)によって
分解を受け、その分解物をシリカゲル薄層クロマドグ2
フイーにかけると、処理後の標品分解物と同じ移動度で
二つのスポットが現れる。
(2) Decomposed by actinomycete hyaluronidase (manufactured by Ohno Pharmaceutical Co., Ltd.), and the decomposed products are collected using silica gel thin layer Chromadog 2.
When applied to a feed, two spots appear with the same mobility as the processed standard decomposition product.

(3)化学組成を分析すると、N−アセチル−D−グル
コサミンとD−グルクロン酸がモル比1:1で存在する
(3) Analysis of the chemical composition reveals that N-acetyl-D-glucosamine and D-glucuronic acid are present in a molar ratio of 1:1.

(4)比施光度は〔α)B = −69°である。(4) The specific light intensity is [α)B = -69°.

(5)薄膜法による赤外吸収スペクトルは第1図の通シ
で標品と同じ。
(5) The infrared absorption spectrum measured by the thin film method is the same as that of the standard product as shown in Figure 1.

(6)重水に溶解して測定した13C−NMRスペクト
ルは第2図の通シで標品と同じ。
(6) The 13C-NMR spectrum measured after dissolving in heavy water is the same as the standard as shown in Figure 2.

(7)分子量は粘度測定法(T、C,Laurent 
et al、。
(7) Molecular weight is determined by viscosity measurement method (T, C, Laurent
et al.

Biochim、Biophys、Acta、 42 
、476−485 。
Biochim, Biophys, Acta, 42
, 476-485.

1960)による結果、200−300万であった。1960), it was 2-3 million.

本発明化粧料には、上記の分子量200万以上のヒアル
ロン酸またはその塩をo、oos〜5.0重量%(以下
単にチと記す)、特に0.05〜2.0%配合するのが
好ましい。ここでヒアルロン酸の塩としては、例えばナ
トリウム塩、カリウム塩、リチウム塩、マグネシムウ塩
、カルシウム塩、リジン塩、アンモニウム塩、トリエタ
ノールアミン塩、ゾロノQノールアミン塩等が挙げられ
る。
In the cosmetics of the present invention, the above-mentioned hyaluronic acid or its salt having a molecular weight of 2 million or more is blended in an amount of o, oos to 5.0% by weight (hereinafter simply referred to as "chi"), particularly 0.05 to 2.0%. preferable. Examples of the salts of hyaluronic acid include sodium salts, potassium salts, lithium salts, magnesium salts, calcium salts, lysine salts, ammonium salts, triethanolamine salts, and ZoronoQ nolamine salts.

本発明化粧料は、前記ヒアルロン酸のほかに通常化粧料
に配合される各種油剤、界面活性剤、防腐剤、粘度調整
剤、薬効剤、他の湿潤剤、香料、アルコール類、水等を
適宜配合することによシ、例えば各種クリーム、乳液、
化粧水、ノQツク、ヘアリンス、ヘアトリートメント、
シャンシー、口紅、ファンデーション、育毛料等の形態
とすることができる。
In addition to the above-mentioned hyaluronic acid, the cosmetics of the present invention may contain various oils, surfactants, preservatives, viscosity modifiers, medicinal agents, other humectants, fragrances, alcohols, water, etc. that are usually incorporated into cosmetics. By blending, for example, various creams, emulsions,
Lotion, NoQ Tsuku, hair rinse, hair treatment,
It can be in the form of shampoo, lipstick, foundation, hair growth agent, etc.

上述の油剤としては流動IQラフイン、ワセリン、IQ
ラフインワックス、スクワラン、みつろう、高級アルコ
ール、脂肪酸等が;界面活性剤としては?リオキシエチ
レン脂肪酸エステル、醪すオキシエチレンソルビタン脂
肪酸エステル、グリセリン脂肪酸エステル、ポリオキク
エチレングリセリン脂肪酸エステル、−リオキシエチレ
ン硬化ヒマシ油、?リオキシエチレンソルビトール脂肪
酸エステル等が;アルコールとしてはエタノール等が:
粘度調整剤としてはカルゼキシメチルセルロース、ヒド
ロキシエチルセルロース、?リビニルアルコール、カル
ボキシビニルポリマー、キサンタンガム等が;湿潤剤と
してはソルビトール、グリセリン、1,3−ブチレング
リコール、ピロリドンカルボン酸ナトリウム、乳酸ナト
リウム、?リエチレングリコール等が;防腐剤としては
ノ9ラオキシ安息香酸アルキルエステル、安息香酸ナト
リウム、ソルビン酸カリウム等が;薬効剤としてはビタ
ミン類、消炎剤、殺菌剤等が挙げられる。
The above-mentioned oils include Liquid IQ Rough-in, Vaseline, IQ
Rough-in wax, squalane, beeswax, higher alcohols, fatty acids, etc.; What about them as surfactants? Lioxyethylene fatty acid ester, oxyethylene sorbitan fatty acid ester, glycerin fatty acid ester, polyoxyethylene glycerin fatty acid ester, -rioxyethylene hydrogenated castor oil, ? Lyoxyethylene sorbitol fatty acid ester, etc.; As alcohol, ethanol etc.:
As viscosity modifiers, calxoxymethyl cellulose, hydroxyethyl cellulose, ? Rivinyl alcohol, carboxyvinyl polymer, xanthan gum, etc.; wetting agents include sorbitol, glycerin, 1,3-butylene glycol, sodium pyrrolidone carboxylate, sodium lactate, etc. Preservatives include alkyl esters of 9-hydroxybenzoic acid, sodium benzoate, potassium sorbate, and the like; medicinal agents include vitamins, anti-inflammatory agents, bactericidal agents, and the like.

〔作用並びに発明の効果〕[Action and effect of the invention]

本発明化粧料に配合される分子量200万以上のヒアル
ロン酸は、従来化粧料に配合されている分子量150万
以下のヒアルロン酸に比べて極めて優れた保湿効果を有
する。従って、これを配合した本発明化粧料は、保湿効
果が高く、かつ使用感、例えば肌への伸び、しつとシ感
、肌へのなめらかさく柔軟性)等が極めて良好なもので
ある。
The hyaluronic acid with a molecular weight of 2,000,000 or more that is blended into the cosmetics of the present invention has an extremely superior moisturizing effect compared to the hyaluronic acid with a molecular weight of 1,500,000 or less that is blended in conventional cosmetics. Therefore, the cosmetic composition of the present invention containing this composition has a high moisturizing effect and has an extremely good feel when used, such as spreadability on the skin, firmness and stiffness, and smoothness and flexibility on the skin.

〔実施例〕〔Example〕

次に参考例及び実施例を挙げ本発明を詳細に説明する。 Next, the present invention will be described in detail with reference to Reference Examples and Examples.

参考例1 生臭粘膜より採取した、β−溶血性を示し、ヒアルロニ
ダーゼを生産し、かつヒアルロン酸を生産するストレゾ
トコツカスΦズーエピデミカスをトッド・ヒユーイツト
0ブロス培地(ディフコ製)中、37℃で10時間培養
し、対数増殖期の菌体を遠心分離によって集め、低温下
遠心分離を繰シ返しつつ2回0.05Mトリス−マレイ
ン酸緩衝液(pH6,0)を用いて無菌的に洗浄した後
、lX108/−の菌濃度となるように同緩衝液に懸濁
し、これにNTGを200μt/11tlとなるよう添
加し37℃にて30分間振とうした。つづいて、低温下
菌体を0.05 M )リス−マレイン酸緩衝液(pH
6,0)で2回洗浄した後、トッド・ヒユーイツト・ブ
ロス培地に接種して37℃、18時間培養した。この培
養液を滅菌生理食塩水にてI X 103/m7!とな
るよう希釈し、その0.1 mを血液(ウサギ脱繊血)
寒天(20m/)に混釈してまき培養後、溶血性を示さ
ない集落を採取した。この変異株の取得頻度は約4XI
O”’6であった。次ぎにこの非溶血性菌株を、上と同
様に、トッド・ヒユーイツト・ブロス培地に37℃で培
養し、対数増殖期の菌体を集め、0.05M)リス−マ
レイン酸緩衝液(pH6,0)で洗浄後、NTG 20
0 ttt/mlを含む同緩衝液中で37℃、20分間
振とうした。つづいて、低温下菌体を同緩衝液で洗浄後
、限外濾過処理培地(トッド・ヒユーイツト・ブロス培
地からアミコン製限外濾過膜YM−10にて高分子画分
を除去したもの)に接種して37℃、18時間培養した
。この培養液を滅菌生理食塩水にて1−5X102/−
となるよう希釈し、そのO,I−をヒアルロン酸ソーダ
(分子量約63万、S i gma社製)0.1%を含
む上記限外濾過処理培地寒天(高純度寒天)上に塗布し
て37℃、20−40時間モイスチャーチャンパー中で
培養し、増殖した集落中の菌をレプリカ法にて採取して
おき、寒天上に10%セチルピリジニュームクロライド
水溶液を噴霧して、約50万の菌株の中から集落周囲が
濁る集落を形成するヒアルロニダーゼ非生産性変異株ス
トレゾトコツカス・ズーエピデミカスYIT 2030
を取得した。
Reference Example 1 Strezotoccoccus Φzoepidemicus, which exhibits β-hemolytic properties, produces hyaluronidase, and produces hyaluronic acid, collected from fishy-smelling mucous membrane, was incubated at 37°C for 10 minutes in Todd-Huyts 0 broth medium (manufactured by Difco). After culturing for an hour, the cells in the logarithmic growth phase were collected by centrifugation, and washed aseptically twice with 0.05M Tris-maleic acid buffer (pH 6.0) while repeating centrifugation at low temperatures. The cells were suspended in the same buffer to a bacterial concentration of 1X108/-, and NTG was added thereto at a concentration of 200 μt/11 tl, followed by shaking at 37° C. for 30 minutes. Subsequently, the microbial cells were incubated at low temperature with 0.05 M) lithium-maleic acid buffer (pH
After washing twice with 6,0), the cells were inoculated into Todd Huyt broth medium and cultured at 37°C for 18 hours. This culture solution was diluted with sterile physiological saline at IX 103/m7! Dilute 0.1 ml of blood (rabbit defibrated blood) to
After plating and culturing in agar (20 m/m), colonies that did not show hemolysis were collected. The acquisition frequency of this mutant strain is approximately 4XI
Next, this non-hemolytic strain was cultured in Todd Huyt broth medium at 37°C in the same manner as above, and the cells in the logarithmic growth phase were collected, and 0.05M) After washing with maleic acid buffer (pH 6,0), NTG 20
The mixture was shaken at 37°C for 20 minutes in the same buffer containing 0 ttt/ml. Subsequently, after washing the bacterial cells at low temperature with the same buffer solution, they were inoculated into an ultrafiltration medium (Todd Huitt broth medium with the polymer fraction removed using Amicon's ultrafiltration membrane YM-10). The cells were then cultured at 37°C for 18 hours. This culture solution was diluted with sterile physiological saline at 1-5X102/-
The O, I- was diluted so that it was applied to the above ultrafiltrated medium agar (high purity agar) containing 0.1% of sodium hyaluronate (molecular weight approximately 630,000, manufactured by Sigma). Cultured in a moisture chamber for 20 to 40 hours at 37°C, the grown bacteria in the colony were collected using the replica method, and a 10% aqueous solution of cetylpyridinium chloride was sprayed onto agar. Hyaluronidase non-producing mutant strain Strezotocochus zooepidemicus YIT 2030 that forms colonies with cloudy surroundings.
obtained.

なお上記ヒアルロニダーゼ生産φ非生産菌の識別法はエ
リカバルケ等の方法(Er1ka−Balke et 
al、 、Zbl、Bakt、Hyg、A、 259 
、194−200.1985)を改変して行った。
The method for identifying the above-mentioned hyaluronidase-producing φ non-producing bacteria is the method of Erika Balke et al.
al, , Zbl, Bakt, Hyg, A, 259
, 194-200.1985).

参考例2  (パッチ培養) グルコース6%、?リペゾトン(大玉栄養化学製)1.
5%、ノ9ン酵母エキス(オリエンタル酵母工業製)0
.5%、燐酸第二カリ0.2%、硫酸マグネシウム7水
塩0.1%、塩化カルシウムo、oos%、アデカノー
ルLG −109(消泡剤 加電化工業製)0.0O1
%の組成の培地(pH7,0)を104tのシャーファ
ーメンタ−に51入れ、滅菌後、前培養したストレゾト
コツカスーズーエピデミカスYIT2030を1%接種
し、6N−水酸化ナトリウム水溶液にて培養pHを7に
連続的に調節しながら37℃で39時間通気攪拌培養し
た。
Reference example 2 (patch culture) Glucose 6%? Ripezoton (manufactured by Otama Nutritional Chemicals) 1.
5%, No9 yeast extract (manufactured by Oriental Yeast Industries) 0
.. 5%, potassium phosphate 0.2%, magnesium sulfate heptahydrate 0.1%, calcium chloride o, oos%, ADEKA NOL LG-109 (antifoaming agent manufactured by Kadenka Kogyo) 0.0O1
% of the culture medium (pH 7.0) was placed in a 104 t Schafer Mentor, and after sterilization, 1% of the pre-cultured Strezotococcus epidemicus YIT2030 was inoculated, and the mixture was mixed with a 6N-sodium hydroxide aqueous solution. The culture was cultured with aeration at 37° C. for 39 hours while the culture pH was continuously adjusted to 7.

グルコースは別滅菌して、培養開始時に一度に添加した
。培養の経過と共に、ヒアルロン酸が蓄積し培養29時
間で、培養液の粘度は8000センチ?アズ近くに達し
ほとんど流動性がなくなシ、培養39時間後、培養液中
のグルコースが零に達した時点で培養を終了した。
Glucose was sterilized separately and added all at once at the start of culture. As the culture progresses, hyaluronic acid accumulates, and after 29 hours of culture, the viscosity of the culture solution is 8000 cm? After 39 hours of culture, the culture was terminated when the glucose in the culture solution reached zero.

収穫した培養液は流動性がないため、これを水にて粘性
が100センチ?アズ以下となるように希釈した。次ぎ
にこの溶液をトリクロル酢酸にてpHを4以下にして、
中空糸マイクロフィルターモジュール(FW−103旭
化成製)に通し、菌体および不溶成分を除去し、更に中
空糸限外濾過膜(I(IF50−43アミコン製)に、
濾過内液に水を注加しながら通し溶液中の低分子物質を
除去した。そしてこの溶液を凍結乾燥法によって乾燥し
ヒアルロン酸を培養液11当たり6.79得た。得られ
たヒアルロン酸の分子量は約216万(粘度測定法)で
あった。
The harvested culture solution has no fluidity, so it is diluted with water to a viscosity of 100 cm. It was diluted to less than az. Next, the pH of this solution was adjusted to 4 or less with trichloroacetic acid,
Pass through a hollow fiber microfilter module (FW-103 manufactured by Asahi Kasei) to remove bacterial cells and insoluble components, and then pass through a hollow fiber ultrafiltration membrane (I (IF50-43 manufactured by Amicon).
Water was added to the filtered solution to remove low-molecular substances in the solution. This solution was dried by freeze-drying to obtain 6.79 hyaluronic acids per 11 culture solutions. The molecular weight of the obtained hyaluronic acid was approximately 2,160,000 (viscosity measurement method).

参考例3  (連続培養) グルコース濃度を25%にした以外は参考例2と同一の
組成の培地をIOA’のシャーファーメンタ−に51入
れ、滅菌後(グルコースは別滅菌)、前培養したストレ
プトコツカス・ズーエピデミカスYIT2030を1%
接種し、6N−水酸化す) IJウム水溶液にて培養p
Hを7に調節しながら、37℃で15時間通気攪拌培養
した。その後グルコース濃度を2優にした以外は参考例
2と同一の組成の培地を、希釈率0.3 (hr−1)
で連続的に注加しながら、37℃、pH7で通気攪拌連
続培養を一週問おこなった。培養槽外に流出した培養液
を一定時間ごとに集め、参考例2と同様にしてヒアルロ
ン酸(分子量約216万〔粘度測定法〕)を抽出精製し
た。この結果、ヒアルロン酸の対糖収率は15%、その
生産性は0.9y / l/ hrであシー日当たp 
21.6 t/lのヒアルロン酸を得ることができた。
Reference Example 3 (Continuous Culture) A medium with the same composition as Reference Example 2 except that the glucose concentration was 25% was placed in an IOA' Schafer Mentor, and after sterilization (glucose was sterilized separately), the pre-cultured streptococcus was cultured. Kotsuka zooepidemicus YIT2030 at 1%
Inoculated and cultured in IJum aqueous solution (6N-hydroxide)
While adjusting H to 7, the culture was carried out with aeration at 37° C. for 15 hours. After that, a medium with the same composition as in Reference Example 2 except that the glucose concentration was changed to 2.0% was used at a dilution rate of 0.3 (hr-1).
Continuous culture with aeration and agitation was carried out at 37° C. and pH 7 for one week while continuously adding water. The culture solution flowing out of the culture tank was collected at regular intervals, and hyaluronic acid (molecular weight approximately 2,160,000 [viscosity measurement method]) was extracted and purified in the same manner as in Reference Example 2. As a result, the yield of hyaluronic acid based on sugar was 15%, and its productivity was 0.9 y/l/hr.
It was possible to obtain 21.6 t/l of hyaluronic acid.

実施例1 表1に示す組成の化粧水を製造し、人間の皮膚に塗布し
たときの保湿効果を、田上らのインピーダンス法(Ta
gami et al、J、Invest。
Example 1 A lotion having the composition shown in Table 1 was manufactured, and the moisturizing effect when applied to human skin was measured using the impedance method of Tagami et al.
Gami et al., J. Invest.

Dermatol、、75 、500〜507 、19
80)を改良した皮表誘電率の測定方法(Karl M
o5ler。
Dermatol, 75, 500-507, 19
Measuring method of skin surface permittivity improved from 80) (Karl M
o5ler.

5onderdruck aus Parfiimer
ie und Kosmetik64.375〜379
.1983)を応用して試験した。なお、表y中、低分
子ヒアルロン酸は鶏のとさか由来のヒアルロン酸(帝国
臓器製薬■)を用い、高分子ヒアルロン酸は参考例2で
得られたものを用いた。また表1中の数値は重量%を示
す。
5onderdruck aus Parfiimer
ie and Kosmetik64.375~379
.. 1983) was applied to the test. In Table y, the low-molecular-weight hyaluronic acid used was chicken comb-derived hyaluronic acid (Teikoku Zoki Seiyaku ■), and the high-molecular-weight hyaluronic acid obtained in Reference Example 2 was used. Moreover, the numerical values in Table 1 indicate weight %.

以下余白 試験方法 健常男子成人(27歳)の上腕内側部を石けんで洗った
後、左右釜3部位、計6部位に4X4I7y+の印をつ
けた。約30分後に皮表水分量測定装置(5KICO8
3、アミックグループ。
Margin Test Method After washing the inner side of the upper arm of a healthy male adult (27 years old) with soap, marks 4X4I7y+ were placed on a total of 6 sites, 3 sites on the left and right pots. Approximately 30 minutes later, the skin surface moisture measuring device (5KICO8
3. Amic Group.

ノロープ直径16fl)を用い、各部位の化粧水塗布前
の皮表誘電率を3回ずつ測定し、平均値を求めた。その
直後に被験化粧水を各部位(16d)  にそれぞれ3
0μ!塗布し、指で充分に伸ばした。そして塗布後経時
的に各部位の皮表誘電率を3回ずつ測定し、各平均値を
求めた。該皮表誘電率から前述の文献(Karl Mo
a1er、5onderdruck aus Parf
ierieund Kosmetik 64 、375
〜379 、1983 )に従い皮表水分含有量を計算
によシ求め、試料塗布前を0とし、皮表水分含有量の変
化として表わした。なお、部位差、誤差をできるだけ少
なくするために化粧水塗布部位をそれぞれ変え、上記測
定を6回くシ返し、平均値を採用した。測定期間中の室
温は27〜29℃、相対湿度は45〜70%であった。
The skin surface permittivity of each area before application of lotion was measured three times using a norope (diameter: 16 fl), and the average value was determined. Immediately after that, apply 3 drops of test lotion to each area (16d).
0μ! Apply it and spread it thoroughly with your fingers. After application, the skin surface permittivity of each site was measured three times over time, and each average value was determined. Based on the skin surface permittivity, the above-mentioned literature (Karl Mo
a1er, 5onderdruck aus Parf
ierieund Kosmetik 64 , 375
The skin surface water content was determined by calculation according to the method of 379, 1983), and the value before application of the sample was set to 0, and it was expressed as a change in the skin surface water content. In order to minimize site differences and errors, the lotion application site was changed and the above measurement was repeated 6 times, and the average value was used. The room temperature during the measurement period was 27-29°C, and the relative humidity was 45-70%.

試験結果 得られた結果を第3図〜第5図に示す。図中、皮表水分
含有量が大きい程、保湿効果が高いことを示す。その結
果、高分子ヒアルロン酸を含有する本発明化粧水は、低
分子ヒアルロン酸を含有する比較品に比べ優れた保湿効
果を有していた。
Test results The results obtained are shown in FIGS. 3 to 5. In the figure, the higher the skin surface moisture content, the higher the moisturizing effect. As a result, the lotion of the present invention containing high molecular weight hyaluronic acid had a superior moisturizing effect compared to the comparative product containing low molecular weight hyaluronic acid.

実施例2 表2に示す組成の化粧水を製造し、人間の皮膚に塗布し
たときの保湿効果を、皮表水分含有量を測定することに
より試験した。皮表水分含有量は実施例1と同様の方法
で測定した皮表誘電率から計算によシ求め、試料塗布前
を0とし、皮表水分の増加量で表わした。
Example 2 A lotion having the composition shown in Table 2 was produced, and its moisturizing effect when applied to human skin was tested by measuring the skin surface water content. The skin surface moisture content was calculated from the skin surface dielectric constant measured in the same manner as in Example 1, and was expressed as the increase in skin surface moisture, with the value before sample application being set to 0.

結果を第6図に示す。なお、測定時の相対湿度は44±
2%、室温は26±1℃であった。
The results are shown in Figure 6. The relative humidity at the time of measurement was 44±
2%, and the room temperature was 26±1°C.

なお、表1中、低分子ヒアルロン酸は分子量約78万の
もの(帝国臓器製薬■製)を用い、高分子ヒアルロン酸
は参考例2により製造したものを用いた。表中の数値は
重量係を示す。
In Table 1, the low molecular weight hyaluronic acid with a molecular weight of about 780,000 (manufactured by Teikoku Zoki Seiyaku ■) was used, and the high molecular weight hyaluronic acid produced according to Reference Example 2 was used. The numbers in the table indicate weight factors.

しり下余白 その結果、本発明化粧水は、いずれも低分子ヒアルロン
酸含有化粧水に比べて優れた保湿効果を示した。
Bottom margin As a result, all of the lotions of the present invention exhibited superior moisturizing effects compared to lotions containing low-molecular-weight hyaluronic acid.

実施例3 表3の組成の化粧水を製造し、その使用感について評価
した。なお表3中の数値は重量%を示す。
Example 3 A lotion having the composition shown in Table 3 was produced, and its feeling of use was evaluated. Note that the numerical values in Table 3 indicate weight %.

評価方法および結果: 表3の化粧水を各々10名(男女各5名)の79ネラ一
の手の甲に一定量塗布してもらい、肌への伸び、キシミ
感、べとつき感、リッチ感、すべすべ感、しつとシ感に
ついてアンケート形式によυ評価させた。
Evaluation method and results: 10 people (5 men and 5 men and women) each applied a certain amount of the lotion shown in Table 3 to the backs of their 79nella hands, and they were asked to apply a certain amount of the lotion shown in Table 3 to the backs of their hands, and they were asked to apply a certain amount of the lotion shown in Table 3 to the backs of their hands, and they were asked to apply a certain amount of the lotion in Table 3 to the backs of their hands. , We asked them to evaluate their sense of comfort using a questionnaire.

その結果、本発明品8は比較量5および6のいずれよシ
も有意に優れた使用感を示した。
As a result, product 8 of the present invention exhibited a significantly superior feeling of use compared to comparative amounts 5 and 6.

また本発明品7は比較量5よシも有意に優れた使用感を
示し、比較量6と同等の使用感を示した。従って、本発
明の配合成分である高分子ヒアルロン酸は従来の低分子
ヒアルロン酸に比べて4分の1の配合量で同等の効果を
発揮するものである。
In addition, product 7 of the present invention exhibited a significantly superior feeling in use compared to comparison amount 5, and exhibited a feeling in use equivalent to comparison amount 6. Therefore, the high-molecular-weight hyaluronic acid, which is a component of the present invention, exhibits the same effect as that of conventional low-molecular-weight hyaluronic acid at one-fourth the amount.

実施例4 下記組成の化粧水を製造し、その使用感について′評価
した。
Example 4 A lotion having the following composition was produced, and its feeling of use was evaluated.

組成: エタノール         8.0 ノQ乏ベン       0.2 1.3−ブチレングリコール    10.0精製水 
  81.6 評価方法および結果: 上記本発明化粧水と高分子ヒアルロン酸の代わシに低分
子ヒアルロン酸(分子量約78万、帝国臓器製薬■製)
を同量配合した化粧水とを各々13名の専門ノQネ2−
に3日づつ使用してもらった。そして、肌への伸び、べ
とつき感、肌へのなめらかさ、しつとυ感の4項目につ
いてアンケート形式によυ評価させた。
Composition: Ethanol 8.0 Q-poor bene 0.2 1.3-butylene glycol 10.0 Purified water
81.6 Evaluation method and results: Low molecular weight hyaluronic acid (molecular weight approximately 780,000, manufactured by Teikoku Zoki Pharmaceutical Co., Ltd.) was used instead of the above-mentioned lotion of the present invention and high molecular weight hyaluronic acid.
A lotion containing the same amount of
I had them use it for 3 days each. The product was then evaluated using a questionnaire on four items: spreadability on the skin, stickiness, smoothness on the skin, and stiffness.

その結果、本発明化粧水は特に肌への伸び、しつとシ感
において低分子ヒアルロン酸配合の化粧水に比べて優れ
たものであった。
As a result, the lotion of the present invention was superior to lotions containing low-molecular-weight hyaluronic acid, especially in terms of spreading on the skin, firmness, and stinging sensation.

実施例5 下記組成の乳液を製造し、その使用感について評価した
Example 5 A milky lotion having the following composition was produced and its feeling in use was evaluated.

組成ニ ステアリン酸        2.5(重量%)牛  
    脂           1.5流動ノQラフ
イン      6.0 ノQ  ラ  ベ  ン              
   0.3モノステアリン酸ンルピタン     1
.51.3−ブチレングリコール     6.0精製
水    79.5 評価方法及び結果: 実施例4と同様の方法によシ評価した結果、本発明乳液
は、低分子ヒアルロン酸配合の乳液に比べて、特に肌へ
の伸び、しつとシ感において優れたものであった。
Composition Nistearic acid 2.5 (wt%) beef
Fat 1.5 fluid Q rough-in 6.0 fluid Q laben
0.3 Monostearate Lupitan 1
.. 51.3-Butylene glycol 6.0 Purified water 79.5 Evaluation method and results: As a result of evaluation using the same method as in Example 4, it was found that the emulsion of the present invention was particularly superior to the emulsion containing low-molecular-weight hyaluronic acid. It had excellent spreadability on the skin, firmness and firmness.

実施例6 下記組成のクリームを製造し、その使用感について評価
した。
Example 6 A cream having the following composition was manufactured and its feeling on use was evaluated.

組成: 流動ノQラフイン      23.0(重量%)ミリ
スチン酸オクチルドデシル   5.0ワ  セ  リ
  ン                 6.0ミ 
  ツ  ロ   ウ               
    5.0ステアリン酸       2hO ベヘニルアルコール    1.0 モノステアリン酸ソルビタン     3.01.3−
ブチレングリコール     3.0ノQ  ラ  ペ
  ン                 0.3精 
 製  水         48.5評価方法及び結
果: 実施例4と同様の方法によシ評価した結果、本発明クリ
ームは、低分子ヒアルロン酸配合のクリームに比べて、
特にべとつき感がなく、肌へのなめらかさ、しつとシ感
において優れたものであった。
Composition: Fluid Q Laugh-in 23.0 (wt%) Octyldodecyl myristate 5.0 Vaseline 6.0 mi
Tsurou
5.0 Stearic acid 2hO Behenyl alcohol 1.0 Sorbitan monostearate 3.01.3-
Butylene glycol 3.0 no Q La Pen 0.3 essence
48.5 Evaluation method and results: As a result of evaluation using the same method as in Example 4, the cream of the present invention had a higher
In particular, it did not have a sticky feeling and was excellent in smoothness and firmness on the skin.

実施例7 下記組成の化粧水を製造した。Example 7 A lotion with the following composition was produced.

組成: ■エタノール       10.0  (重量%)■
1,3−ブチレングリコール    2.0■メチルノ
Q2ペン      0.1■香    料     
      0.1■精 製 水         全
体で100となる量製法: ■に■を分散し、これに■、■、■、■および■を加え
て十分攪拌することによシ化粧水を得た。
Composition: ■Ethanol 10.0 (wt%)■
1,3-butylene glycol 2.0■Methylno Q2 pen 0.1■Fragrance
0.1 ■Purified water A total amount of 100 Production method: ■Dispersed in ■, Added ■, ■, ■, ■, and ■ to this and sufficiently stirred to obtain a lotion.

実施例8 下記組成の乳液を製造した。Example 8 A milky lotion having the following composition was produced.

組成: ■ステアリン酸        2.0(重量%)■流
動ノQラフイン      6.0■スクワラン   
   2.0 ■ンルピタンモノステアレート1.5 ■ゾチルノQラベン      0.05■1,3−ブ
チレングリコール    3.0■メチルノ92ペン 
      0.1[相]香      料     
     0.15■精  製  水       全
体で100となる量製法: ■に■および■を加え、■を分散し、分散液を得る。次
いでこれを80℃で■〜■に加えて乳化し、その後[相
]を加えて室温まで冷却して乳液を得た。
Composition: ■ Stearic acid 2.0 (wt%) ■ Fluid Q Rough In 6.0 ■ Squalane
2.0 ■ Nlupitan Monostearate 1.5 ■ Zotylno Q Laben 0.05 ■ 1,3-Butylene Glycol 3.0 ■ Methylno 92 Pen
0.1 [phase] fragrance
0.15■ Purified water Amount that makes the total 100 Production method: Add ■ and ■ to ■ and disperse ■ to obtain a dispersion. Next, this was added to ① to ② at 80°C to emulsify, and then [phase] was added and cooled to room temperature to obtain a milky lotion.

実施例9 下記組成のクリームを製造した。Example 9 A cream having the following composition was produced.

組成: ■流動ノQラフイン      23.0  (重量係
)■ワ  セ  リ  ン             
 7.0■セタノール      1.0 ■ステアリン酸       zO ■ ミ   ツ  ロ  ウ            
    2.0■ソルビタンモノステアレート    
 3.5■ブチル、Qラベン      0.05[相
]1,3−ブチレングリコール     3.0■メチ
ルノQラベン       0.1@香     料 
         0.15◎精  製  水    
    全体で100となる量製法: [相]に[相]および■を加え、これに■を分散せしめ
て分散液を得る。次いでこれを80℃で■〜■に加えて
乳化し、その後@を加えて室温まで冷却してクリームを
得た。
Composition: ■Fluid Q rough-in 23.0 (weight) ■Vaseline
7.0 ■ Cetol 1.0 ■ Stearic acid zO ■ Beeswax
2.0 ■ Sorbitan monostearate
3.5 ■ Butyl, Q Laben 0.05 [Phase] 1,3-butylene glycol 3.0 ■ Methyl Q Laben 0.1 @Fragrance
0.15◎Purified water
Production method for a total amount of 100: Add [phase] and ■ to [phase], and disperse ■ into this to obtain a dispersion. Next, this was added to ① to ① at 80°C to emulsify it, and then @ was added and cooled to room temperature to obtain cream.

実施例10 下記組成の育毛料を製造した。Example 10 A hair growth agent having the following composition was produced.

以下余白 実施例11 下記組成のヘアリンスを製造した。Margin below Example 11 A hair rinse having the following composition was manufactured.

41一 実施例12 下記組成のシャンプーを製造した。41-1 Example 12 A shampoo having the following composition was manufactured.

42一 実施例13 下記組成のファンデーションを製造した。421 Example 13 A foundation having the following composition was manufactured.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図および第2図は参考例2で得られた高分子ヒアル
ロン酸の赤外線吸収スペクトルおよびNMRスペクトル
をそれぞれ示す図面である。 第3図〜第5図は、実施例1の化粧水を塗布したときの
、皮表水分含有量の変化と塗布後の時間との関係を示す
図面である。 第6図は実施例2の化粧水を塗布したときの皮表水分含
有量の変化と塗布後の時間との□ 関係を示す図面であ
る。 以上 第3図 塗布後の時間(分) 第4図 塗布後の時間(分)
FIG. 1 and FIG. 2 are drawings showing the infrared absorption spectrum and NMR spectrum of the polymeric hyaluronic acid obtained in Reference Example 2, respectively. 3 to 5 are drawings showing the relationship between changes in skin surface moisture content and time after application when the lotion of Example 1 is applied. FIG. 6 is a drawing showing the relationship between the change in skin surface moisture content and the time after application when the lotion of Example 2 is applied. Figure 3: Time after application (minutes) Figure 4: Time after application (minutes)

Claims (1)

【特許請求の範囲】 1、分子量200万以上のヒアルロン酸またはその塩を
含有することを特徴とする化粧料。 2、分子量200万以上のヒアルロン酸が微生物によつ
て産生されるものである特許請求の範囲第1項記載の化
粧料。 3、分子量200万以上のヒアルロン酸を産生する微生
物がストレプトコツカス・ズーエピデミカスに属する細
菌である特許請求の範囲第2項記載の化粧料。 4、分子量200万以上のヒアルロン酸を産生する微生
物がストレプトコツカス・ズーエピデミカスYIT20
30(微工研菌寄第8746号)である特許請求の範囲
第2項もしくは第3項記載の化粧料。
[Scope of Claims] 1. A cosmetic containing hyaluronic acid or a salt thereof having a molecular weight of 2 million or more. 2. The cosmetic according to claim 1, wherein the hyaluronic acid having a molecular weight of 2 million or more is produced by microorganisms. 3. The cosmetic according to claim 2, wherein the microorganism that produces hyaluronic acid with a molecular weight of 2 million or more is a bacterium belonging to Streptococcus zooepidemicus. 4. The microorganism that produces hyaluronic acid with a molecular weight of over 2 million is Streptococcus zooepidemicus YIT20
30 (Keikoken Bokuyori No. 8746), according to claim 2 or 3.
JP61302922A 1986-05-01 1986-12-19 Cosmetic containing hyaluronic acid Pending JPS63156707A (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP61302922A JPS63156707A (en) 1986-12-19 1986-12-19 Cosmetic containing hyaluronic acid
US07/038,907 US5023175A (en) 1986-05-01 1987-04-16 Novel production process of hyaluronic acid and bacterium strain therefor
CA000535098A CA1314508C (en) 1986-05-01 1987-04-21 Production process of hyaluronic acid and bacterium strain therefor as well as cosmetic composition containing hyaluronic acid
AU71960/87A AU598809B2 (en) 1986-05-01 1987-04-24 Novel production process of hyaluronic acid and bacterium strain therefor as well as cosmetic composition containing hyaluronic acid
KR1019870003999A KR960005736B1 (en) 1986-05-01 1987-04-25 Novel production process of hyaluronic acid
EP87106247A EP0244757B1 (en) 1986-05-01 1987-04-29 Novel production process of hyaluronic acid and bacterium strain therefor as well as cosmetic composition containing hyaluronic acid
DE3750733T DE3750733T2 (en) 1986-05-01 1987-04-29 Process for the production of hyaluronic acid, bacterial strains required therefor and cosmetic composition which contains hyaluronic acid.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61302922A JPS63156707A (en) 1986-12-19 1986-12-19 Cosmetic containing hyaluronic acid

Publications (1)

Publication Number Publication Date
JPS63156707A true JPS63156707A (en) 1988-06-29

Family

ID=17914736

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61302922A Pending JPS63156707A (en) 1986-05-01 1986-12-19 Cosmetic containing hyaluronic acid

Country Status (1)

Country Link
JP (1) JPS63156707A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100558751B1 (en) 2004-10-18 2006-03-14 주식회사 태평양 Cosmetic composition for skin miosture
WO2009099120A1 (en) 2008-02-06 2009-08-13 Toray Industries, Inc. Aqueous dispersion containing polysaccharide particulate gel and method for producing the same

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5856692A (en) * 1981-09-26 1983-04-04 Shiseido Co Ltd Preparation of hyaluronic acid
JPS60251898A (en) * 1984-05-25 1985-12-12 Shiseido Co Ltd Preparation of hyaluronic acid by fermentation method
JPS614760A (en) * 1984-06-11 1986-01-10 バイオマトリツクス,インコ−ポレイテツド Hyaluronate-poly(ethylene oxide) composition and cosmetic medicine
JPS61129106A (en) * 1984-11-20 1986-06-17 フアルマカ・エツセ・エルレ・エルレ Dermaphilic cosmetic composition
JPS61219394A (en) * 1985-03-25 1986-09-29 Shiseido Co Ltd Production of hyaluronic acid through fermentation
JPS61239898A (en) * 1985-04-16 1986-10-25 Chisso Corp Production of hyaluronic acid
JPS6251999A (en) * 1985-09-02 1987-03-06 Kyowa Hakko Kogyo Co Ltd Production of hyaluronic acid
JPS62158203A (en) * 1986-01-06 1987-07-14 Pola Chem Ind Inc Cosmetic
JPS63156838A (en) * 1986-12-11 1988-06-29 バイオマトリックス インコーポレーテッド Improved hyaluronate-poly(ethylene oxide) composition
JPS63273490A (en) * 1986-10-09 1988-11-10 Mitsubishi Rayon Co Ltd Production of hyaluronic acid

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5856692A (en) * 1981-09-26 1983-04-04 Shiseido Co Ltd Preparation of hyaluronic acid
JPS60251898A (en) * 1984-05-25 1985-12-12 Shiseido Co Ltd Preparation of hyaluronic acid by fermentation method
JPS614760A (en) * 1984-06-11 1986-01-10 バイオマトリツクス,インコ−ポレイテツド Hyaluronate-poly(ethylene oxide) composition and cosmetic medicine
JPS61129106A (en) * 1984-11-20 1986-06-17 フアルマカ・エツセ・エルレ・エルレ Dermaphilic cosmetic composition
JPS61219394A (en) * 1985-03-25 1986-09-29 Shiseido Co Ltd Production of hyaluronic acid through fermentation
JPS61239898A (en) * 1985-04-16 1986-10-25 Chisso Corp Production of hyaluronic acid
JPS6251999A (en) * 1985-09-02 1987-03-06 Kyowa Hakko Kogyo Co Ltd Production of hyaluronic acid
JPS62158203A (en) * 1986-01-06 1987-07-14 Pola Chem Ind Inc Cosmetic
JPS63273490A (en) * 1986-10-09 1988-11-10 Mitsubishi Rayon Co Ltd Production of hyaluronic acid
JPS63156838A (en) * 1986-12-11 1988-06-29 バイオマトリックス インコーポレーテッド Improved hyaluronate-poly(ethylene oxide) composition

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100558751B1 (en) 2004-10-18 2006-03-14 주식회사 태평양 Cosmetic composition for skin miosture
WO2009099120A1 (en) 2008-02-06 2009-08-13 Toray Industries, Inc. Aqueous dispersion containing polysaccharide particulate gel and method for producing the same

Similar Documents

Publication Publication Date Title
KR960005736B1 (en) Novel production process of hyaluronic acid
KR100302504B1 (en) Fermented product using lactic acid bacteria and cosmetic composition
CN111534455B (en) Preparation of lactobacillus sporolysis product and application of lactobacillus sporolysis product in cosmetics
DE3531612C2 (en)
JPH06128138A (en) Cosmetic
JP4000078B2 (en) Skin moisturizer
JP3184114B2 (en) Moisturizer
JP2814003B2 (en) External preparation for skin
JP2618658B2 (en) Skin cosmetics
CN115414308B (en) Acne-removing composition, preparation method and application
CN111904909A (en) Dandruff-removing scalp essence containing rose fermentation liquor and preparation method thereof
JPH05286843A (en) Skin cosmetic containing culture mixture of suehirotake @(3754/24)schizophyllum commue)
KR100467068B1 (en) Lactococcus lactis CBT-19, manufacturing method of the culture broth concentration and the cosmetic preparation
JP3686170B2 (en) Cosmetics
JPS63156707A (en) Cosmetic containing hyaluronic acid
DD222895A5 (en) PROCESS FOR PREPARING A HYPOTRIGLYCERIDEMICALLY ACTIVE POLYSACCHARIDE
JP2004507613A (en) Non-sulfated fucose-based oligosaccharide mixtures, cosmetic or pharmaceutical compositions comprising said mixtures, and their use in cosmetics or pharmacy
JPWO2015012198A1 (en) Moisturizer
JPH07126143A (en) Cosmetic
JPS63230613A (en) Cosmetic
JP3413220B2 (en) Skin roughness improver
WO2020096059A1 (en) External agent for hair growth or hair loss prevention
JP3172599B2 (en) Cell activator
JP3579134B2 (en) Cosmetics
JPS62273905A (en) Cosmetic